Evoke Pharma Market Cap 2012-2023 | EVOK

Evoke Pharma market cap history and chart from 2012 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Evoke Pharma market cap as of April 24, 2024 is $0B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.004B $0.005B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.585B 5.27
Dr Reddy's Laboratories (RDY) India $11.835B 18.71
Aspen Pharmacare (APNHY) South Africa $4.900B 0.00
BridgeBio Pharma (BBIO) United States $4.401B 0.00
Bausch Health Cos (BHC) Canada $3.128B 2.44
Amphastar Pharmaceuticals (AMPH) United States $2.004B 13.71
Supernus Pharmaceuticals (SUPN) United States $1.656B 0.00
Taysha Gene Therapies (TSHA) United States $0.439B 0.00
Generation Bio (GBIO) United States $0.199B 0.00
Assembly Biosciences (ASMB) United States $0.074B 0.00
Personalis (PSNL) United States $0.066B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Teligent (TLGT) United States $0.000B 0.00